Article information
Full text is only aviable in PDF
References
[1.]
World Health Organization. Geneva: World health report. Available from: http://www.who.int/whr/2000/en/statistics.htm. 2000.
[2.]
S.S. Hurd.
International efforts directed at attacking the problem of COPD.
Chest, 117 (2000), pp. 336-338
[3.]
P. Stang, E. Lydick, C. Silberman, A. Kempel, E.T. Keating.
The prevalence of COPD: using smoking rates to estimate disease frequency in the general population.
Chest, 117 (2000), pp. 354-359
[4.]
S. Hurd.
The impact of COPD on lung health worldwide: epidemiology and incidence.
Chest, 117 (2000), pp. 1-4
[5.]
V.S. Pena, M. Miravitlles, R. Gabriel, C.A. Jimenez-Ruiz, C. Villasante, J.F. Masa, et al.
Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study.
Chest, 118 (2000), pp. 981-989
[6.]
K.F. Rabe, S. Hurd, A. Anzueto, P.J. Barnes, S.A. Buist, P. Calverley, et al.
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.
Am J Respir Crit Care Med, 176 (2007), pp. 532-555
[7.]
C.D. Mathers, D. Loncar.
Projections of global mortality and burden of disease from 2002-2030.
PLoS Med, 3 (2006), pp. e442
[8.]
A.G. Agusti, A. Noguera, J. Sauleda, E. Sala, J. Pons, X. Busquets.
Systemic effects of chronic obstructive pulmonary disease.
Eur Respir J, 21 (2003), pp. 347-360
[9.]
E.F. Wouters, E.C. Creutzberg, A.M. Schols.
Systemic effects in COPD.
Chest, 121 (2002), pp. 127-130
[10.]
A. Domingo-Salvany, R. Lamarca, M. Ferrer, J. Garcia-Aymerich, J. Alonso, M. Felez, et al.
Health-related quality of life and mortality in male patients with chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 166 (2002), pp. 680-685
[11.]
I. Solanes, P. Casan, M. Sangenis, N. Calaf, B. Giraldo, R. Guell.
Factores de riesgo de mortalidad en la EPOC.
Arch Bronconeumol, 43 (2007), pp. 445-449
[12.]
F.J. Martinez, G. Foster, J.L. Curtis, G. Criner, G. Weinmann, A. Fishman, et al.
Predictors of mortality in patients with emphysema and severe airflow obstruction.
Am J Respir Crit Care Med, 173 (2006), pp. 1326-1334
[13.]
A.L. Ries, R.M. Kaplan, T.M. Limberg, L.M. Prewitt.
Effects of pulmonary rehabilitation on physiologic and psychosocial outcomes in patients with chronic obstructive pulmonary disease.
Ann Intern Med, 122 (1995), pp. 823-832
[14.]
A. Moreno, C. Monton, Y. Belmonte, M. Gallego, X. Pomares, J. Real.
Causas de muerte en pacientes con EPOC grave. Factores pronósticos.
Arch Bronconeumol, 45 (2009), pp. 181-186
[15.]
N.R. Anthonisen, E.C. Wright, J.E. Hodgkin.
Prognosis in chronic obstructive pulmonary disease.
Am Rev Respir Dis, 133 (1986), pp. 14-20
[16.]
K. Nishimura, T. Izumi, M. Tsukino, T. Oga.
Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD.
Chest, 121 (2002), pp. 1434-1440
[17.]
T. Oga, K. Nishimura, M. Tsukino, S. Sato, T. Hajiro.
Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status.
Am J Respir Crit Care Med, 167 (2003), pp. 544-549
[18.]
J.B. Bowen, J.J. Votto, R.S. Thrall, M.C. Haggerty, R. Stockdale-Woolley, T. Bandyopadhyay, et al.
Functional status and survival following pulmonary rehabilitation.
Chest, 118 (2000), pp. 697-703
[19.]
A.M. Schols, J. Slangen, L. Volovics, E.F. Wouters.
Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 157 (1998), pp. 1791-1797
[20.]
C. Tantucci, P. Donati, F. Nicosia, E. Bertella, S. Redolfi, M. De Vecchi, et al.
Inspiratory capacity predicts mortality in patients with chronic obstructive pulmonary disease.
Respir Med, 102 (2008), pp. 613-619
[21.]
C. Casanova, C. Cote, J.P. de Torres, A. Aguirre-Jaime, J.M. Marin, V. Pinto-Plata, et al.
Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 171 (2005), pp. 591-597
[22.]
J.J. Hospers, D.S. Postma, B. Rijcken, S.T. Weiss, J.P. Schouten.
Histamine airway hyperresponsiveness and mortality from chronic obstructive pulmonary disease: a cohort study.
Lancet, 356 (2000), pp. 1313-1317
[23.]
J.J. Soler-Cataluña, M.A. Martínez-García, P. Román Sánchez, E. Salcedo, M. Navarro, R. Ochando.
Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease.
Thorax, 60 (2005), pp. 925-931
[24.]
O. Fruchter, M. Yigla.
Predictors of long-term survival in elderly patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease.
Respirology, 13 (2008), pp. 851-855
[25.]
J.P. Torres, E. Cordoba-Lanus, C. Lopez-Aguilar, M. Muros de Fuentes, A. Montejo de Garcini, A. Aguirre-Jaime, et al.
C-reactive protein levels and clinically important predictive outcomes in stable COPD patients.
Eur Respir J, 27 (2006), pp. 902-907
[26.]
M. Dahl, J. Vestbo, P. Lange, S. Bojesen, A. Tybjaerg-Hansen.
Nordestgaard. C-reactive protein as a predictor factor of prognosis in chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 175 (2007), pp. 250-255
[27.]
E. Prescott, T. Almdal, K.L. Mikkelsen, C.L. Tofteng, J. Vestbo, P. Lange.
Prognostic value of weight change in chronic obstructive pulmonary disease: results from the Copenhagen City Heart Study.
Eur Respir J, 20 (2002), pp. 539-544
[28.]
C. Landbo, E. Prescott, P. Lange, J. Vestbo, T.P. Almdal.
Prognostic value of nutritional status in chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 160 (1999), pp. 1856-1861
[29.]
K. Marquis, R. Debigare, Y. Lacasse, P. LeBlanc, J. Jobin, G. Carrier, et al.
Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 166 (2002), pp. 809-813
[30.]
A. Schols, R. Broekhuizen, C. Weling-Scheepers, E. Wouters.
Body compositiona and mortality in chronic obstructive pulmonary disease.
Am J Clin Nutr, 82 (2005), pp. 53-59
[31.]
C. Casanova, C. Cote, J.M. Marin, V. Pinto-Plata, J.P. de Torres, A. Aguirre-Jaime, et al.
Distance and oxygen desaturation during the 6-min walk test as predictors of long-term mortality in patients with COPD.
Chest, 134 (2008), pp. 746-752
[32.]
C.G. Cote, V. Pinto-Plata, K. Kasprzyk, L.J. Dordelly, B.R. Celli.
The 6-min walk distance, peak oxygen uptake, and mortality in COPD.
Chest, 132 (2007), pp. 1778-1785
[33.]
B.R. Celli, C.G. Cote, J.M. Marin, C. Casanova, M. Montes de Oca, R.A. Mendez, et al.
The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease.
N Engl J Med, 350 (2004), pp. 1005-1012
[34.]
J.P. de Torres, C.G. Cote, M.V. Lopez, C. Casanova, O. Diaz, J.M. Marin, et al.
Sex differences in mortality in patients with COPD.
Eur Respir J, 33 (2009), pp. 528-535
[35.]
C.G. Cote, V.M. Pinto-Plata, J.M. Marin, H. Nekach, L.J. Dordelly, B.R. Celli.
The modified BODE index: validation with mortality in COPD.
Eur Respir J, 32 (2008), pp. 1269-1274
[36.]
J.J. Soler-Cataluña, M.A. Martinez-Garcia, L.S. Sanchez, M.P. Tordera, P.R. Sanchez.
Severe exacerbations and BODE index: two independent risk factors for death in male COPD patients.
Respir Med, 103 (2009), pp. 692-699
[37.]
A. Briggs, M. Spencer, H. Wang, D. Mannino, D.D. Sin.
Development and validation of a prognostic index for health outcomes in chronic obstructive pulmonary disease.
Arch Intern Med, 168 (2008), pp. 71-79
[38.]
M.A. Puhan, J. García-Aymerich, M. Frey, G. ter Riet, J.M. Antó, A.G. Agustí, et al.
Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index.
Lancet, 374 (2009), pp. 704-711
[39.]
Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial.
Nocturnal Oxygen Therapy Trial Group.
Ann Intern Med, 93 (1980), pp. 391-398
[40.]
Report of the Medical Research Council Working Party.
Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema.
Lancet, 1 (1981), pp. 681-686
[41.]
D. Gorecka, K. Gorzelak, P. Sliwinski, M. Tobiasz, J. Zielinski.
Effect of long-term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxaemia.
Thorax, 52 (1997), pp. 674-679
[42.]
A.L. Ries, G.S. Bauldoff, B.W. Carlin, R. Casaburi, C.F. Emery, D.A. Mahler, et al.
Pulmonary Rehabilitation: Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines.
Chest, 131 (2007), pp. 4-42
[43.]
S. Barakat, G. Michele, P. George, V. Nicole, A. Guy.
Outpatient pulmonary rehabilitation in patients with chronic obstructive pulmonary disease.
Int J Chron Obstruct Pulmon Dis, 3 (2008), pp. 155-162
[44.]
M.A. Puhan, M. Scharplatz, T. Troosters, J. Steurer.
Respiratory rehabilitation after acute exacerbation of COPD may reduce risk for readmission and mortality – a systematic review.
Respir Res, 6 (2005), pp. 54
[45.]
B.R. Celli, N.E. Thomas, J.A. Anderson, G.T. Ferguson, C.R. Jenkins, P.W. Jones, et al.
Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study.
Am J Respir Crit Care Med, 178 (2008), pp. 332-338
[46.]
D.P. Tashkin, B. Celli, S. Senn, D. Burkhart, S. Kesten, S. Menjoge, et al.
A 4-year trial of tiotropium in chronic obstructive pulmonary disease.
N Engl J Med, 359 (2008), pp. 1543-1554
[47.]
J.A. Wedzicha, P.M. Calverley, T.A. Seemungal, G. Hagan, Z. Ansari, R.A. Stockley.
The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide.
Am J Respir Crit Care Med, 177 (2008), pp. 19-26
[48.]
C.C. Dobler, K.K. Wong, G.B. Marks.
Associations between statins and COPD: a systematic review.
BMC Pulm Med, 12 (2009), pp. 9-32
Copyright © 2010. Sociedad Española de Neumología y Cirugía Torácica
